These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37345941)

  • 1. Mutation in the two-component regulator BaeSR mediates cefiderocol resistance and enhances virulence in
    Liu X; Chang Y; Xu Q; Zhang W; Huang Z; Zhang L; Weng S; Leptihn S; Jiang Y; Yu Y; Hua X
    mSystems; 2023 Aug; 8(4):e0129122. PubMed ID: 37345941
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii.
    Lin MF; Lin YY; Lan CY
    PLoS One; 2015; 10(7):e0132843. PubMed ID: 26161744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility.
    Lin MF; Lin YY; Yeh HW; Lan CY
    BMC Microbiol; 2014 May; 14():119. PubMed ID: 24885279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of Cefiderocol Against
    Iregui A; Khan Z; Landman D; Quale J
    Microb Drug Resist; 2020 Jul; 26(7):722-726. PubMed ID: 32031915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hetero-antagonism of avibactam and sulbactam with cefiderocol in carbapenem-resistant
    Wong O; Mezcord V; Lopez C; Traglia GM; Pasteran F; Tuttobene MR; Corso A; Tolmasky ME; Bonomo RA; Ramirez MS
    Microbiol Spectr; 2024 Oct; 12(10):e0093024. PubMed ID: 39162493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients.
    Zhang J; Xie J; Li H; Wang Z; Yin Y; Wang S; Chen H; Wang Q; Wang H
    Microbiol Spectr; 2022 Feb; 10(1):e0159321. PubMed ID: 35044218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Efflux Pumps from Different Superfamilies in the Surface-Associated Motility and Virulence of
    Pérez-Varela M; Corral J; Aranda J; Barbé J
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefiderocol Resistance in Acinetobacter baumannii: Roles of β-Lactamases, Siderophore Receptors, and Penicillin Binding Protein 3.
    Malik S; Kaminski M; Landman D; Quale J
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in biofilm formation and transcription of biofilm-associated genes among Acinetobacter baumannii clinical strains belonging to the international clone II lineage.
    Kishii K; Hamada M; Aoki K; Ito K; Onodera J; Ishii Y; Tateda K
    J Infect Chemother; 2020 Jul; 26(7):693-698. PubMed ID: 32249162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF; Lin YY; Tu CC; Lan CY
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii.
    Salehi B; Ghalavand Z; Yadegar A; Eslami G
    Antimicrob Resist Infect Control; 2021 Mar; 10(1):53. PubMed ID: 33691788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence.
    Kollef M; Dupont H; Greenberg DE; Viale P; Echols R; Yamano Y; Nicolau DP
    Int J Antimicrob Agents; 2023 Aug; 62(2):106882. PubMed ID: 37301312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transcriptomic and genomic analyses in improving the comprehension of cefiderocol activity in
    Stracquadanio S; Nicolosi A; Privitera GF; Massimino M; Marino A; Bongiorno D; Stefani S
    mSphere; 2024 Jan; 9(1):e0061723. PubMed ID: 38078714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
    Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
    Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of PER-1-Mediated Cefiderocol Resistance and Synergistic Inhibition of PER-1 by Cefiderocol in Combination with Avibactam or Durlobactam in Acinetobacter baumannii.
    Liu X; Lei T; Yang Y; Zhang L; Liu H; Leptihn S; Yu Y; Hua X
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0082822. PubMed ID: 36377939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of the Ade Resistance-Nodulation-Cell Division-Type Efflux Pumps to Fitness and Pathogenesis of Acinetobacter baumannii.
    Yoon EJ; Balloy V; Fiette L; Chignard M; Courvalin P; Grillot-Courvalin C
    mBio; 2016 May; 7(3):. PubMed ID: 27247231
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ito A; Sato T; Ota M; Takemura M; Nishikawa T; Toba S; Kohira N; Miyagawa S; Ishibashi N; Matsumoto S; Nakamura R; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro resistance development gives insights into molecular resistance mechanisms against cefiderocol.
    Kriz R; Spettel K; Pichler A; Schefberger K; Sanz-Codina M; Lötsch F; Harrison N; Willinger B; Zeitlinger M; Burgmann H; Lagler H
    J Antibiot (Tokyo); 2024 Nov; 77(11):757-767. PubMed ID: 39080477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability.
    Stracquadanio S; Bonomo C; Marino A; Bongiorno D; Privitera GF; Bivona DA; Mirabile A; Bonacci PG; Stefani S
    Microbiol Spectr; 2022 Oct; 10(5):e0234722. PubMed ID: 36173300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.